Phase Ib/II study of nivolumab in combination with azacytidine in patients with relapsed AML
Phase Ib/II study of nivolumab in combination with azacytidine in patients with relapsed AML
Metabolic adaptations to targeted therapy in FLT3 mutated acute myeloid leukaemia
Safety and efficacy of blinatumomab for acute lymphoblastic leukaemia
TGR-1202, ublituximab and ibrutinib combination for advanced CLL and NHL
FDG-PET guidance allows substantial chemoreduction in Hodgkin lymphoma
Interim analysis of the JULIET study
ZUMA1 trial of CD19 CAR T cells for aggressive NHL
Cerdulatinib demonstrates rapid responses in a phase 2 study for relapsed/refractory NHL
European guidelines for breast cancer treatment
ESMO ranking of the clinical benefits of new drugs
Europa Uomo - improving prostate cancer patients quality of life across Europe
Personalised medicine for rare cancers